These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19659629)

  • 21. A multiple ion channel blocker, NIP-142, for the treatment of atrial fibrillation.
    Tanaka H; Hashimoto N
    Cardiovasc Drug Rev; 2007; 25(4):342-56. PubMed ID: 18078434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug therapy for atrial fibrillation: what will its role be in the era of increasing use of catheter ablation?
    Morrow JP; Reiffel JA
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):108-18. PubMed ID: 19140921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiology and disease progression of atrial fibrillation: importance of achieving and maintaining sinus rhythm.
    Cohen M; Naccarelli GV
    J Cardiovasc Electrophysiol; 2008 Aug; 19(8):885-90. PubMed ID: 18373600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Food and Drug Administration and atrial defibrillation devices.
    Chen L; Keane AT; Every NR
    Am J Manag Care; 1999 Jul; 5(7):899-909. PubMed ID: 10557410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
    Aronow WS
    Cardiol Rev; 2008; 16(4):181-8. PubMed ID: 18562808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical management of atrial fibrillation: state of the art.
    Camm J
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S2-6. PubMed ID: 16939435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of stable atrial fibrillation in the emergency department: a population-based comparison of electrical direct-current versus pharmacological cardioversion or conservative management.
    Dankner R; Shahar A; Novikov I; Agmon U; Ziv A; Hod H
    Cardiology; 2009; 112(4):270-8. PubMed ID: 18815445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial fibrillation and the expanding role of catheter ablation: do antiarrhythmic drugs have a future?
    Naccarelli GV; Gonzalez MD
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):203-9. PubMed ID: 18806600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defibrillation testing in patients with atrial fibrillation.
    Lim HS; Lip GY
    Europace; 2009 Aug; 11(8):1108-9. PubMed ID: 19549676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?
    Ehrlich JR; Nattel S
    Curr Opin Cardiol; 2009 Jan; 24(1):50-5. PubMed ID: 19077816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The rationale and design of the FORomegaARD Trial: A randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation.
    Macchia A; Varini S; Grancelli H; Nul D; Laffaye N; Ferrante D; Tognoni G; Doval HC;
    Am Heart J; 2009 Mar; 157(3):423-7. PubMed ID: 19249410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial fibrillation in patients with implantable defibrillators.
    Sakhuja R; Shah AJ; Keebler M; Thakur RK
    Cardiol Clin; 2009 Feb; 27(1):151-61, ix-x. PubMed ID: 19111771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection of drugs in pursuit of a rhythm control strategy.
    Kowey PR; Stoenescu ML
    Prog Cardiovasc Dis; 2005; 48(2):139-45. PubMed ID: 16253653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Catheter ablation of atrial fibrillation in patients with structural heart disease: when to think about it?].
    Gaita F; Di Donna P; Caponi D; Scaglione M
    G Ital Cardiol (Rome); 2009 Sep; 10(9):572-9. PubMed ID: 19891249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Restoration and maintenance of sinus rhythm in patients with atrial fibrillation. New pharmacological approaches].
    Runge S; Dietz R; Haverkamp W
    Dtsch Med Wochenschr; 2008 Dec; 133(49):2572-8. PubMed ID: 19039713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized evaluation of right atrial ablation after left atrial ablation of complex fractionated atrial electrograms for long-lasting persistent atrial fibrillation.
    Oral H; Chugh A; Good E; Crawford T; Sarrazin JF; Kuhne M; Chalfoun N; Wells D; Boonyapisit W; Gadeela N; Sankaran S; Kfahagi A; Jongnarangsin K; Pelosi F; Bogun F; Morady F
    Circ Arrhythm Electrophysiol; 2008 Apr; 1(1):6-13. PubMed ID: 19808388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rate control vs rhythm control strategies in atrial fibrillation.
    Wyse DG
    Prog Cardiovasc Dis; 2005; 48(2):125-38. PubMed ID: 16253652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiarrhythmic Drug Therapy for Rhythm Control in Atrial Fibrillation.
    Waks JW; Zimetbaum P
    J Cardiovasc Pharmacol Ther; 2017 Jan; 22(1):3-19. PubMed ID: 27260643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New antiarrhythmic drugs for establishing sinus rhythm in atrial fibrillation: what are our therapies likely to be by 2010 and beyond?
    Morrow JP; Cannon CP; Reiffel JA
    Am Heart J; 2007 Nov; 154(5):824-9. PubMed ID: 17967585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A contemporary look at classic trials in atrial fibrillation: what do they really show and how might they apply to future therapies?
    Reiffel JA
    Am J Cardiol; 2008 Sep; 102(6A):3H-11H. PubMed ID: 18790109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.